Neuropsychological impairments in elderly Neurofibromatosis type 1 patients

European Journal of Medical Genetics

Volumn 57, Issue 5, 2014, Pages 216-219

  Costa, Danielle de Souza ^a   de Paula, Jonas Jardim ^a   de Rezende, Nilton Alves ^a   Rodrigues, Luiz Oswaldo Carneiro ^a   Malloy Diniz, Leandro Fernandes ^a   Romano Silva, Marco Aurélio ^a   Miranda, Débora Marques de ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Aging; Cognition; Elderly; Neurofibromatosis type 1; Neuropsychology

Indexed keywords

AGED; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEPTH PERCEPTION; EPISODIC MEMORY; EXECUTIVE FUNCTION; FEMALE; GERIATRIC PATIENT; HUMAN; LANGUAGE; LIFESPAN; MALE; MINI MENTAL STATE EXAMINATION; NEUROFIBROMATOSIS; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGY; SEMANTIC MEMORY; VERBAL MEMORY; WORKING MEMORY; MIDDLE AGED; PSYCHOLOGY; SHORT TERM MEMORY;

AGED; CASE-CONTROL STUDIES; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROFIBROMATOSIS 1;

EID: 84899633250     PISSN: 17697212     EISSN: 18780849     Source Type: Journal    
DOI: 10.1016/j.ejmg.2014.02.004     Document Type: Article

References (30)

1. Alves L., Simões M.R., Martins C., Freitas S., Santana I. Premorbid IQ influence on screening tests' scores in healthy patients and patients with cognitive impairment. J Geriatr Psychiatry Neurol 2013 Jun, 26(2):117-126.
2. Baiyewu O., Unverzagt F.W., Lane K.A., Gureje O., Ogunniyi A., Musick B., et al. The stick design test: a new measure of visuoconstructional ability. J Int Neuropsychol Soc 2005, 11(5):598-605.
3. Burke S.N., Barnes C.A. Neural plasticity in the ageing brain. Nat Rev Neurosci 2006, 7(1):30-40.
4. Carey J.C., Baty B.J., Johnson J.P., Morrison T., Skolnick M., Kivlin J. The genetic aspects of neurofibromatosis. Ann N Y Acad Sci 1986, 486:45-56.
5. Castro-Costa E., Fuzikawa C., Uchoa E., Firmo J.O., Lima-Costa M.F. Norms for the mini-mental state examination: adjustment of the cut-offpoint in population-based studies (evidences from the Bambuí health aging study). Arq Neuropsiquiatr 2008, 66(3A):524-528.
6. de Paula J.J., Schlottfeldt C.G., Moreira L., Cotta M., Bicalho M.A., Romano-Silva M.A., et al. Psychometric properties of a brief neuropsychological protocol for use in geriatric populations. Rev Psiquiatr Clín 2010, 37(6):246-250.
7. de Paula J.J., Costa D.S., Moraes E.N., Nicolato R., Sedó M., Malloy-Diniz L.F. Automatic and controlled attentional processes in amnestic mild cognitive impairment: the use of a mini-verbal test. Psychology 2012, 3(5):370-383.
8. de Paula J.J., Cunha L.M.P., Nicolato R., Moraes E.N., Bicalho M.A., Hamdan A.C., et al. Reliability and construct validity of the Rey-Auditory Verbal Learning Test in Brazilian elders. Rev Psiquiatr Clín 2012, 39(1):19-23.
9. de Paula J.J., Moura S.M., Bocardi M.B., Moraes E.N., Malloy-Diniz L.F., Haase V.G. Screening for executive dysfunction with the frontal assessment battery: psychometric properties analysis and representative normative data for Brazilian older adults. Psicol em Pesqui 2013, 7(1):1-10.
10. Descheemaeker M.J., Plasschaert E., Frijns J.P., Legius E. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group. J Intellect Disabil Res 2012 Oct 24.
11. Ehninger D., Li W., Fox K., Stryker M.P., Silva A.J. Reversing neurodevelopmental disorders in adults. Neuron 2008, 60:950-960.
12. Goh J.O. Functional dedifferentiation and altered connectivity in older adults: neural accounts of cognitive aging. Aging Dis 2011, 2(1):30-48.
13. Gutmann D.H., Aylsworth A., Carey J.C., Korf B., Marks J., Pyeritz R.E., et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis1and neurofibromatosis 2. JAMA 1997, 278:51-57.
14. Gutmann D.H., Parada L.F., Silva A.J., Ratner N. Neurofibromatosis type 1: modeling CNS dysfunction. J Neurosci 2012, 32(41):14087-14093.
15. Gysin S., Salt M., Young A., McCormick F. Therapeutic strategies for targeting ras proteins. Genes Cancer 2011, 2:359-372.
16. Hachon C., Iannuzzi S., Chaix Y. Behavioural and cognitive phenotypes in children with neurofibromatosis type 1 (NF1): the link with the neurobiological level. Brain Dev 2011, 33(1):52-61.
17. Hyman S.L., Gill D., Shores E.A., Steinberg A., Joy P., Gibikote S.V., et al. Natural history of neuropsychological ability and T2-hyperintensities in patients with neurofibromatosis type 1. Neurology 2003, 60:1139-1145.
18. Hyman S.L., Shores A., North K.N. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology 2005, 65:1037-1044.
19. Kaasinen V., Vilkman H., Hietala J., Nagren K., Helenius H., Olsson H., et al. Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain. Neurobiol Aging 2000, 21(5):683-688.
20. Lehtonen A., Howie E., Trump D., Huson S.M. Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence. Develop Med Child Neurol 2013, 55(2):111-125.
21. Li W., Cui Y., Kushner S.A., Brown R.A., Jentsch J.D., Frankland P.W., et al. The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr Biol 2005, 15:1961-1967.
22. Lu P.H., Lee G.J., Tishler T.A., Meghpara M., Thompson P.M., Bartzokis G. Myelin breakdown mediates age-related slowing in cognitive processing speed in healthy elderly men. Brain Cogn 2013, 81(1):131-138.
23. Malloy-Diniz L.F., Bentes R.C., Figueiredo P.M., Brandão-Bretas D., Costa-Abranches S., Parizzi A.M., et al. Normalización de una batería de tests para evaluarlas habilidades de comprensióndellenguaje, fluidez verbal y denominaciónenniñosbrasileños de 7 a 10 años: resultados preliminares. Rev Neurol 2007, 44(5):275-280.
24. Mayes D.A., Rizvi T.A., Titus-Mitchell H., Oberst R., Ciraolo G.M., Vorhees C.V., et al. Nf1 loss and ras hyperactivation in oligodendrocytes induce NOS-driven defects in myelin and vasculature. Cell Rep 2013 Sep 11, S2211-1247(13)00435-X.
25. North K.N., Riccardi V., Samango-Sprouse C., Ferner R., Moore B., Legius E., et al. Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 cognitive disorders task force. Neurology 1997, 48:1121-1127.
26. Pasmant E., Vidaud M., Vidaud D., Wolkenstein P. Neurofibromatosis type 1: from genotype to phenotype. J Med Genet 2012, 49:483-489.
27. Payne J.M., Moharir M.D., Webster R., North K.N. Brain structure and function in neurofibromatosis type 1: current concepts and future directions. J Neurol Neurosurg Psychiatry 2010, 81(3):304-309.
28. Schrimsher G.W., Billingsley R.L., Slopis J.M., Moore B.D. Visual-spatial performance deficits in children with neurofibromatosis type-1. Am J Med Genet 2003, 120A:326-330.
29. Shilyansky C., Karlsgodt K.H., Cummings D.M., Sidiropoulou K., Hardt M., James A.S., et al. Neurofibromin regulates corticostriatal inhibitory networks during working memory performance. Proc Natl Acad Sci U S A 2010, 107:13141-13146.
30. Silva A.J., Frankland P.W., Marowitz Z., Friedman E., Laszlo G.S., CioffiD., et al. Amousemodel for the learning and memory deficits associated with neurofibromatosis type I. Nat Genet 1997, 15:281-284.